Pivotal bioVenture Partners China: Funding, Team & Investors | Startup Intros

Loading organizations...

Pivotal bioVenture Partners China: Funding, Team & Investors | Startup Intros

Financial History

Total Raised

N/A

Valuation

N/A

Investments Made

Date	Company	Round	Lead Investor(s)	Co-Investor(s)
Jan 2, 2024	Heranova Lifesciences	$13.5M Seed	—	Emerging Technology Partners, Sinovation Ventures
Nov 1, 2021	Ablaze Pharmaceuticals	$75.0M Series A	Vivo Capital, Advantech Capital	Novo Ventures, venBio, Nan Fung Life Sciences, RAYZ Investments, Samsara BioCapital, Venrock
Mar 1, 2021	Arctic Vision	$100.0M Series B	Roy Xie	CVentures, Adrian Cheng, Morningside Ventures, Nan Fung Life Sciences, Octagon Capital, Tencent
Jan 1, 2021	Visen Pharmaceuticals	$150.0M Series B	Hongshan Capital Group (Sequoia Capital China)	Qiming Venture Partners, Vivo Capital, Michael Wolff Jensen, CDG Capital, Cormorant Asset Management, HBM Healthcare Investments, Logos Capital, OrbiMed, Sherpa Healthcare Partners, Sofinnova Ventures
Jun 1, 2019	OncXerna Therapeutics	$80.0M Series B	Nan Fung Life Sciences, Peter Bisgaard	Avalon Ventures, Domain Associates, OrbiMed, Osage University Partners, Pivotal bioVenture Partners, RiverVest, Heather Preston, Korea Investment Partners
Jun 7, 2018	OncXerna Therapeutics	$16.5M Seed	Jimmy Wei	CMB International, Peter Bisgaard, Volcanics Venture